Nurix Therapeutics, Inc. NRIX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s total liabilities & equity?
- Nurix Therapeutics, Inc. (NRIX) reported total liabilities & equity of $636.13M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Nurix Therapeutics, Inc.'s total liabilities & equity increased by 3.4% year-over-year, from $615.04M to $636.13M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s total liabilities & equity has grown at a 11.7% compound annual growth rate (CAGR), from $396.34M to $688.14M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.